There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Edwards Lifesciences Corporation (EW) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $76.03. The Edwards Lifesciences Corporation has recorded 108,039 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed EDWARDS HIGHLIGHTS NEW DATA AT ACC RELATED TO LIFETIME MANAGEMENT OF AORTIC STENOSIS.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
As a NYSE listed company, EW falls under the Healthcare sector while operating within the Medical Devices industry segment. At the end of the last regular session, the stock closed at $76.03 and fluctuated between $78.12 as its day high and $75.95 as its day low. The current market capitalization of Edwards Lifesciences Corporation is $45.30B. A total of 2.49 million shares were traded on the day, compared to an average of 3.65M shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, EW has seen 12 BUY and 14 SELL insider trades, representing the acquisition of 118,337 and the disposition of 94,496 shares. Over the last 12 months, there were 90 BUYs and 143 SELLs from insiders. Insiders purchased 1,038,141 shares during that period but sold 790,848.
In the most recent transaction, BOBO DONALD E JR sold 6,725 shares of EW for 76.96 per share on Mar 08. After the transaction, the CVP,Strategy/Corp Development now owns 62,561 company shares. In a previous transaction on Mar 08, Lemercier Jean-Luc M sold 6,640 shares at 76.96 per share. EW shares that CVP, EMEACLA and JAPAC owns now total 168,875.
Among the insiders who sold shares, STONE HEISZ LESLIE disposed of 9,671 shares on Feb 16 at a per-share price of $76.82. This resulted in the Director holding 27,480 shares of EW after the transaction. In another insider transaction, Chopra Daveen sold 4,000 shares at $76.01 per share on Feb 15. Company shares held by the CVP, TMTT now total 18,911.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for EW in the last 3 months, the mean price target is $87.41 with high estimates of $100.00 and low estimates of $67.00. In terms of 52-week highs and lows, EW has a high of $131.10 and a low of $67.13.
As of this writing, EW has an earnings estimate of $0.61 per share for the current quarter. EPS was calculated based on a consensus of 20 estimates, with a high estimate of $0.64 per share and a lower estimate of $0.55. The company reported an EPS of $0.61 in the last quarter, which was -1.60% lower than expectations of $0.62.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 29 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EW is Sell with a score of 4.16. A total of 13 analysts rated the stock as Buy while 2 rated it as Overweight while 13 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 0 thought it should be Sold.